基于网络药理学预测菟丝子-枸杞子药对治疗生精功能障碍的有效成分和潜在靶点
DOI:
作者:
作者单位:

中国中医科学院中医基础理论研究所,北京,100700,中国

作者简介:

通讯作者:

中图分类号:

基金项目:


Network Pharmacology-based Strategy for Predicting Active Ingredients and Potential Targets of Cuscutae semen and Lycii fructus in Spermatogenic Dysfunction Author links open overlay panel
Author:
Affiliation:

Institute of Basic Theory for Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    背景:传统中药菟丝子(SC,Cuscuta chinensis Lam.)和枸杞子(FL,Lycium barbarum L.)被用作药对(SC-FL)来治疗各种疾病,包括生精功能障碍(SD),这是一种导致男性低生育率的疾病。目的:为此,我们将进一步确定用于治疗SD的SC-FL药对的生物活性成分、成分的靶点和部分分子机制。方法:我们使用中药药理学数据库结合UHPLC分析SC-FL药对的活性成分,并探讨其治疗生精功能障碍(SD)的可能靶点和潜在机制。此外,我们使用雷公藤多甙(GTW)来制备SD大鼠模型,以评估SC-FL是否通过预测的潜在途径对SD产生影响,以及从网络药理学分析中获得的某些关键靶点和途径的可靠性。结果:我们确定了SC-LF中的56种活性成分以及影响SD治疗结果的41个靶点。经过Gene Ontology (GO)、Kyoto Encyclopedia of Gene and Genome pathway(KEGG)的富集分析,获得了262个GO生物学途径和170条相关通路。从中我们预测细胞增殖和凋亡是参与SC-LF治疗SD的主要生物学过程。结果表明,在SD模型中,SC-FL治疗显著提高了睾丸器官系数、精子计数和运动能力,同时减少了睾丸损伤和睾丸组织细胞凋亡。从机制上讲,SC-FL显著上调了抗凋亡蛋白BCL2的表达水平和AR的表达水平,下调了促凋亡蛋白BAD、BAX、cleaved CASP3和CASP3的表达水平。结论:总之,这些结果表明SC-FL通过潜在地调节细胞凋亡而发挥保护作用,因此表明它将是治疗男性不育的有效制剂。

    Abstract:

    Background Traditional Chinese Medicine (TCM) Cuscutae semen (SC, Tusizi from Cuscuta chinensis Lam.) and Lycii fructus (FL, Gouqi from Lycium barbarum L.), are also used as a herb pair (SC-FL) to treat various ailments, including spermatogenic dysfunction (SD), a disease responsible for low fertility in males. Objective Herein, we will further determine the bioactive components, component targets and partial molecular mechanisms of the herb pair for the treatment of SD. Methods We employed the traditional Chinese medicine systems pharmacology database in combination with Ultra high performance liquid chromatography (UHPLC) analysis to analyze the active ingredients of the SC-FL herbal pair and explore its possible targets and underlying mechanism in treatment of spermatogenic dysfunction (SD). Moreover, we used a Sprague-Dawley rat model, generated by using glucosides of Tripterygium wilfordii (GTW), to evaluate the effect of SC-FL and the underlying mechanism on SD and reliability of certain key targets and pathways obtained from the pharmacology analysis. Results We identified 56 active ingredients in SC-LF affecting 41 overlapping gene signals that influenced SD treatment outcomes. 262 Gene Ontology (GO) terms and 170 pathways were yielded under analyses of Gene Ontology, Kyoto Encyclopedia of Gene and Genome pathway from which we predicted that cell proliferation and apoptosis were the primary biological processes (BP) involved in the treatment of SD by SC-LF. The results showed that SC-FL treatment significantly improved the testicular organ coefficient along with sperm count and motility, while reduced testicular damage and testicular tissue cell apoptosis in SD model. Mechanistically, SC-FL significantly upregulated the expression levels of anti-apoptotic proteins AR and BCL2 and downregulated those of pro-apoptotic proteins BAD, BAX, cleaved caspase 3, and CASP3. Conclusion Collectively, these results indicated that SC-FL elicited a protective effect by potentially regulating apoptosis, thus suggesting that it will represent an effective reagent for male infertility.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-11-24
  • 出版日期: